Temelkova-Kurktschiev T - Search Results

1

The postprandial state and the risk of atherosclerosis.

Hanefeld M, Temelkova-Kurktschiev T. Hanefeld M, et al. Diabet Med. 1997 Aug;14 Suppl 3:S6-11. doi: 10.1002/(sici)1096-9136(199708)14:3+3.3.co;2-8. Diabet Med. 1997. PMID: 9272607 Review.

2

Oral glucose tolerance test: to be or not to be performed?

Temelkova-Kurktschiev TS, Hanefeld M. Temelkova-Kurktschiev TS, et al. Clin Lab. 2002;48(3-4):143-52. Clin Lab. 2002. PMID: 11934216 Review.

3

Pulse pressure is a strong predictor of cardiovascular risk: Data of the risk factors in impaired glucose tolerance for atherosclerosis and diabetes and the Sofia Metabolic Syndrome studies.

Temelkova-Kurktschiev TS, Kurktschiev DP, Vladimirova-Kitova LG, Koehler C, Henkel E, Todorova BR, Schaper F, Fuecker K, Hanefeld M. Temelkova-Kurktschiev TS, et al. Folia Med (Plovdiv). 2009 Jan-Mar;51(1):34-41. Folia Med (Plovdiv). 2009. PMID: 19437896

4

Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.

Temelkova-Kurktschiev T, Hanefeld M, Chinetti G, Zawadzki C, Haulon S, Kubaszek A, Koehler C, Leonhardt W, Staels B, Laakso M. Temelkova-Kurktschiev T, et al. J Clin Endocrinol Metab. 2004 Sep;89(9):4238-42. doi: 10.1210/jc.2003-032120. J Clin Endocrinol Metab. 2004. PMID: 15356014

5

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.

Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Hanefeld M, et al. Stroke. 2004 May;35(5):1073-8. doi: 10.1161/01.STR.0000125864.01546.f2. Epub 2004 Apr 8. Stroke. 2004. PMID: 15073402 Clinical Trial.

6

Leukocyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes.

Temelkova-Kurktschiev T, Koehler C, Henkel E, Hanefeld M. Temelkova-Kurktschiev T, et al. Cardiovasc Res. 2002 Nov;56(2):277-83. doi: 10.1016/s0008-6363(02)00547-3. Cardiovasc Res. 2002. PMID: 12393098

7

In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.

Kopprasch S, Pietzsch J, Kuhlisch E, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M, Kühne H, Julius U, Graessler J. Kopprasch S, et al. Diabetes. 2002 Oct;51(10):3102-6. doi: 10.2337/diabetes.51.10.3102. Diabetes. 2002. PMID: 12351454

8

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Hanefeld M, et al. Diabetes Care. 2003 Mar;26(3):868-74. doi: 10.2337/diacare.26.3.868. Diabetes Care. 2003. PMID: 12610051

9

The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.

Temelkova-Kurktschiev T, Hanefeld M. Temelkova-Kurktschiev T, et al. Exp Clin Endocrinol Diabetes. 2004 Feb;112(2):75-9. doi: 10.1055/s-2004-815753. Exp Clin Endocrinol Diabetes. 2004. PMID: 15031770 Review.

10

[Significance of postprandial glucose peaks for development of diabetic macroangiopathy].

Temelkova-Kurktschiev T. Temelkova-Kurktschiev T. Ther Umsch. 2002 Aug;59(8):411-4. doi: 10.1024/0040-5930.59.8.411. Ther Umsch. 2002. PMID: 12235733 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results